首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Exploration of targeted antitumor therapy

缩写:

ISSN:2692-3114

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引375
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Majid Banimohammad,Parsa Khalafi,Danial Gholamin et al. Majid Banimohammad et al.
The purpose of this review was to provide a comprehensive review of the latest insights on the pathogenesis of uveal melanoma (UM) and its intracellular pathways. This article covers the epidemiology of UM, racial predispositions, cytogenet...
Bruno A Cesca,Kali Pellicer San Martin,Matías D Caverzan et al. Bruno A Cesca et al.
Glioblastoma (GBM), the most aggressive and lethal primary brain tumor, poses a significant therapeutic challenge due to its highly invasive nature and resistance to conventional therapies, including surgery, chemotherapy, and radiotherapy....
Eljie Isaak Bragasin,Justin Cheng,Lauren Ford et al. Eljie Isaak Bragasin et al.
Small cell lung cancer (SCLC) is an aggressive tumor characterized by early metastasis and resistance to treatment, making it a prime target for therapeutic investigation. The current standard of care for frontline treatment involves a comb...
Evgeny N Imyanitov,Elena V Preobrazhenskaya,Natalia V Mitiushkina Evgeny N Imyanitov
Although immune checkpoint inhibitors (ICIs) are widely used in clinical oncology, less than half of treated cancer patients derive benefit from this therapy. Both tumor- and host-related variables are implicated in response to ICIs. The pr...
Dominik Godlewski,Dorota Bartusik-Aebisher,Sara Czech et al. Dominik Godlewski et al.
Bladder cancer (BCa) is among the most frequently diagnosed urinary tract cancers, characterized by a high recurrence rate and significant clinical heterogeneity. Effective diagnosis and treatment of BCa demand continuous advancements in me...
Vittore Cereda,Mario Rosario D&#x;Andrea Vittore Cereda
Pancreatic cancer is a challenging disease with limited treatment options and a high mortality rate. Just few therapy advances have been made in recent years. Tumor microenvironment, immunosuppressive features and mutational status represen...
Daniel Thomas Jones,Hazem Aboaid,Ramaditya Srinivasmurthy et al. Daniel Thomas Jones et al.
Background: Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of malignant plasma cells in the bone marrow, constituting approximately 13% of all hematologic malignancies. Isatuxi...
Luis Cabezón-Gutiérrez,Magda Palka-Kotlowska,Sara Custodio-Cabello et al. Luis Cabezón-Gutiérrez et al.
Immunotherapy has revolutionized cancer treatment, yet its efficacy is frequently compromised by metabolic mechanisms that drive resistance. Understanding how tumor metabolism shapes the immune microenvironment is essential for developing e...
Amil Shah Amil Shah
The discovery of oncogenes and tumor suppressor genes led to a better understanding of tumorigenesis, and prompted the development of molecularly targeted therapy. Over the past 30 years, many new drugs, which are primarily aimed at activat...
Dhyas Munandar Arya Sasmita,Kavi Gilang Permana,Teguh Aryandono et al. Dhyas Munandar Arya Sasmita et al.
Background: Telomere length is a potential prognostic biomarker in breast cancer, but its clinical utility remains uncertain due to inconsistent findings across the literature. This systematic review and meta-analysis aim...